Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-04-10
1989-10-17
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514520, 514521, 548253, 562426, 562429, 562431, C07D25704, A61K 3141, A61K 3105, C07C 3902
Patent
active
048747777
ABSTRACT:
This invention provides benzene derivatives which are leukotriene antagonists, formulations of those derivatives, and a method of using those derivatives for the treatment of conditions characterized by an excessive release of leukotrienes.
REFERENCES:
patent: 3899513 (1975-08-01), Warren et al.
patent: 4281008 (1981-07-01), Chamberlain et al.
patent: 4424231 (1984-01-01), Bantick et al.
patent: 4474788 (1984-10-01), Bantick
patent: 4499299 (1985-02-01), Bernstein et al.
patent: 4567279 (1986-01-01), Chan
patent: 4617407 (1986-10-01), Young et al.
patent: 4628115 (1986-12-01), Carson et al.
patent: 4644071 (1987-02-01), Masatern et al.
patent: 4650812 (1987-03-01), Cohen et al.
Derwent 86-219907/34 Abstracting EPO 191,401.
Dillard et al., J. Med. Chem., 30(5), 911 (1987).
Carr F. Patrick
Dillard Robert D.
McCullough Doris E.
Conrad Robert A.
Eli Lilly and Company
Springer David B.
Whitaker Leroy
LandOfFree
Leukotriene antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leukotriene antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leukotriene antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1743856